|
|
GeneNews Limited - Comparative Business Analysis Snapshot
Business Description
GeneNews Limited. The Group's principal activity is to develop proprietary molecular diagnostic tests for diseases with unmet clinical needs and large commercial opportunities. The tests are based on the Company's breakthrough Sentinel Principle and are being developed in the areas of cancer, cardiovascular diseases, central nervous system disorders and arthritis. The Group operates only in the Canada.
Competitor Analysis
This analysis compares GeneNews Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
